ARTG 281303NanoBone Granulate - Bone matrix implant, synthetic
ARTG ID: 281303 · Emergo Asia Pacific Pty Ltd T/a Emergo Australia · Artoss GmbH · Class III · Started October 12, 2016
Good Name: Emergo Asia Pacific Pty Ltd T/a Emergo Australia - NanoBone Granulate - Bone matrix implant, synthetic
- Risk Class
- Class III
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 281303
- Start Date
- October 12, 2016
- Effective Date
- October 12, 2016
- Name
- Artoss GmbH
- Country
- Germany
- Address
- Fischerweg 421, Rostock, 18069
NanoBone Granulate is a bone void filler material that is intended to be used for orthopaedic applications as a filler for gaps and voids that are not intrinsic to the stability of the bony structure. It is a sterile bioabsorbable device made of synthetic material intended to be implanted into the body and is provided in granulate form of various sizes.
Access comprehensive regulatory information for NanoBone Granulate - Bone matrix implant, synthetic in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 281303 and sponsored by Emergo Asia Pacific Pty Ltd T/a Emergo Australia, manufactured by Artoss GmbH in Germany. The device registration started on October 12, 2016.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.